410 related articles for article (PubMed ID: 25449906)
1. Sigma-1 receptor is involved in degradation of intranuclear inclusions in a cellular model of Huntington's disease.
Miki Y; Tanji K; Mori F; Wakabayashi K
Neurobiol Dis; 2015 Feb; 74():25-31. PubMed ID: 25449906
[TBL] [Abstract][Full Text] [Related]
2. Accumulation of the sigma-1 receptor is common to neuronal nuclear inclusions in various neurodegenerative diseases.
Miki Y; Mori F; Kon T; Tanji K; Toyoshima Y; Yoshida M; Sasaki H; Kakita A; Takahashi H; Wakabayashi K
Neuropathology; 2014 Apr; 34(2):148-58. PubMed ID: 24313828
[TBL] [Abstract][Full Text] [Related]
3. Herp Promotes Degradation of Mutant Huntingtin: Involvement of the Proteasome and Molecular Chaperones.
Luo H; Cao L; Liang X; Du A; Peng T; Li H
Mol Neurobiol; 2018 Oct; 55(10):7652-7668. PubMed ID: 29430620
[TBL] [Abstract][Full Text] [Related]
4. Mutant huntingtin expression in clonal striatal cells: dissociation of inclusion formation and neuronal survival by caspase inhibition.
Kim M; Lee HS; LaForet G; McIntyre C; Martin EJ; Chang P; Kim TW; Williams M; Reddy PH; Tagle D; Boyce FM; Won L; Heller A; Aronin N; DiFiglia M
J Neurosci; 1999 Feb; 19(3):964-73. PubMed ID: 9920660
[TBL] [Abstract][Full Text] [Related]
5. Brain region- and age-dependent dysregulation of p62 and NBR1 in a mouse model of Huntington's disease.
Rué L; López-Soop G; Gelpi E; Martínez-Vicente M; Alberch J; Pérez-Navarro E
Neurobiol Dis; 2013 Apr; 52():219-28. PubMed ID: 23295856
[TBL] [Abstract][Full Text] [Related]
6. Gedunin Degrades Aggregates of Mutant Huntingtin Protein and Intranuclear Inclusions via the Proteasomal Pathway in Neurons and Fibroblasts from Patients with Huntington's Disease.
Yang W; Xie J; Qiang Q; Li L; Lin X; Ren Y; Ren W; Liu Q; Zhou G; Wei W; Saiyin H; Ma L
Neurosci Bull; 2019 Dec; 35(6):1024-1034. PubMed ID: 31432317
[TBL] [Abstract][Full Text] [Related]
7. A cellular model that recapitulates major pathogenic steps of Huntington's disease.
Lunkes A; Mandel JL
Hum Mol Genet; 1998 Sep; 7(9):1355-61. PubMed ID: 9700187
[TBL] [Abstract][Full Text] [Related]
8. Calmodulin regulates transglutaminase 2 cross-linking of huntingtin.
Zainelli GM; Ross CA; Troncoso JC; Fitzgerald JK; Muma NA
J Neurosci; 2004 Feb; 24(8):1954-61. PubMed ID: 14985437
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of endoplasmic reticulum stress counteracts neuronal cell death and protein aggregation caused by N-terminal mutant huntingtin proteins.
Reijonen S; Putkonen N; Nørremølle A; Lindholm D; Korhonen L
Exp Cell Res; 2008 Mar; 314(5):950-60. PubMed ID: 18255062
[TBL] [Abstract][Full Text] [Related]
10. Selection of behaviors and segmental coordination during larval locomotion is disrupted by nuclear polyglutamine inclusions in a new Drosophila Huntington's disease-like model.
Nishimura Y; Yalgin C; Akimoto S; Doumanis J; Sasajima R; Nukina N; Miyakawa H; Moore AW; Morimoto T
J Neurogenet; 2010 Dec; 24(4):194-206. PubMed ID: 21087194
[TBL] [Abstract][Full Text] [Related]
11. Complex interplay between the length and composition of the huntingtin-derived peptides modulates the intracellular behavior of the N-terminal fragments of mutant huntingtin.
Milewski M; Gawliński P; Bąk D; Matysiak A; Bal J
Eur J Cell Biol; 2015 May; 94(5):179-89. PubMed ID: 25773959
[TBL] [Abstract][Full Text] [Related]
12. Ubiquitin-proteasome system alterations in a striatal cell model of Huntington's disease.
Hunter JM; Lesort M; Johnson GV
J Neurosci Res; 2007 Jun; 85(8):1774-88. PubMed ID: 17455294
[TBL] [Abstract][Full Text] [Related]
13. Huntington's disease intranuclear inclusions contain truncated, ubiquitinated huntingtin protein.
Sieradzan KA; Mechan AO; Jones L; Wanker EE; Nukina N; Mann DM
Exp Neurol; 1999 Mar; 156(1):92-9. PubMed ID: 10192780
[TBL] [Abstract][Full Text] [Related]
14. Baclofen, a GABAB receptor agonist, enhances ubiquitin-proteasome system functioning and neuronal survival in Huntington's disease model mice.
Kim W; Seo H
Biochem Biophys Res Commun; 2014 Jan; 443(2):706-11. PubMed ID: 24333873
[TBL] [Abstract][Full Text] [Related]
15. Tissue transglutaminase selectively modifies proteins associated with truncated mutant huntingtin in intact cells.
Chun W; Lesort M; Tucholski J; Faber PW; MacDonald ME; Ross CA; Johnson GV
Neurobiol Dis; 2001 Jun; 8(3):391-404. PubMed ID: 11442349
[TBL] [Abstract][Full Text] [Related]
16. Dopamine D1 receptor-mediated aggregation of N-terminal fragments of mutant huntingtin and cell death in a neuroblastoma cell line.
Robinson P; Lebel M; Cyr M
Neuroscience; 2008 May; 153(3):762-72. PubMed ID: 18403126
[TBL] [Abstract][Full Text] [Related]
17. Mutant huntingtin and glycogen synthase kinase 3-beta accumulate in neuronal lipid rafts of a presymptomatic knock-in mouse model of Huntington's disease.
Valencia A; Reeves PB; Sapp E; Li X; Alexander J; Kegel KB; Chase K; Aronin N; DiFiglia M
J Neurosci Res; 2010 Jan; 88(1):179-90. PubMed ID: 19642201
[TBL] [Abstract][Full Text] [Related]
18. The huntingtin N17 domain is a multifunctional CRM1 and Ran-dependent nuclear and cilial export signal.
Maiuri T; Woloshansky T; Xia J; Truant R
Hum Mol Genet; 2013 Apr; 22(7):1383-94. PubMed ID: 23297360
[TBL] [Abstract][Full Text] [Related]
19. Progressive phenotype and nuclear accumulation of an amino-terminal cleavage fragment in a transgenic mouse model with inducible expression of full-length mutant huntingtin.
Tanaka Y; Igarashi S; Nakamura M; Gafni J; Torcassi C; Schilling G; Crippen D; Wood JD; Sawa A; Jenkins NA; Copeland NG; Borchelt DR; Ross CA; Ellerby LM
Neurobiol Dis; 2006 Feb; 21(2):381-91. PubMed ID: 16150600
[TBL] [Abstract][Full Text] [Related]
20. Differential morphology and composition of inclusions in the R6/2 mouse and PC12 cell models of Huntington's disease.
Wanderer J; Morton AJ
Histochem Cell Biol; 2007 May; 127(5):473-84. PubMed ID: 17285342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]